Mountain View
biomedical and healthCAre Data Discovery Index Ecosystem
help Advanced Search
Title: Cocaine Use Reduction with Buprenorphine (CURB)      
ID:
NIDA-CTN-0048
creators:
Walter Ling, M.D.
privacy:
information not available
keywords:
naltrexone; cocaine; buprenorphine
refinement:
curated
types:
clinical trial
dateReleased:
04-24-2015
aggregation:
instance of dataset
availability:
available
description:
This was a randomized, controlled trial that enrolled 302 cocaine-dependent participants who had either past-year opioid dependence or past-year opioid abuse or past-year opioid use with a history of opioid dependence during the lifetime. Participants were randomized to one of three treatment arms: 1) placebo plus naltrexone, 2) 4mg buprenorphine plus naltrexone, and 3) 16mg buprenorphine plus naltrexone. Participants received 8 weeks of pharmacotherapy, with thrice weekly clinic visits. The primary aim of the study was to compare the number of cocaine use days during the 30-day evaluation period (the final 30 days of active medication administration prior to taper; days 25-54) amongst the treatment groups. The study also evaluated a number of secondary outcome measures.
name:
Homo sapiens
ID:
SCR:011440
homePage: http://www.nida.nih.gov/
abbreviation:
NIDA
name:
National Institute on Drug Abuse
ID:
SCR:002002
homePage: http://datashare.nida.nih.gov/
abbreviation:
CTN
name:
Clinical Trials Network Data Share

Feedback?

If you are having problems using our tools, or if you would just like to send us some feedback, please post your questions on GitHub.